LYNCH ZACK received a stock award from PEAR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 12/7/2021ACC: 0001062993-21-012390
+10.80M
Net shares
Net buyer
$100.0K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
10.80M acquired
Non-Derivative Transactions3
Class A Common Stock
Indirect
Shares
+1.08M
Price / share
—
Trade value
—
% of position
New position
12/3/2021
0.00→1.08M
Class A Common Stock
Indirect
Shares
+9.67M
Price / share
—
Trade value
—
% of position
New position
12/3/2021
0.00→9.67M
Class A Common Stock
Indirect
Shares
+10K
Price / share
$10.00
Trade value
$100K
% of position
0.1%
12/3/2021
9.67M→9.68M
Total
Net shares
+10.77M
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 12/3/2021 | A · Award | +1.08M | — | — | New position | 0.00 | 1.08M |
| Class A Common Stock Indirect | 12/3/2021 | A · Award | +9.67M | — | — | New position | 0.00 | 9.67M |
| Class A Common Stock Indirect | 12/3/2021 | A · Award | +10K | $10.00 | $100K | 0.1% | 9.67M | 9.68M |
| Total | +10.77M | $100K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
29.45K shares
Shares
+29.45K
Strike price
0.02
Held after
29.45K
Exercisable
—
12/3/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock29.45K shares | 12/3/2021 | A · Award | +29.45K | 0.02 | — | 29.45K |